申请人:SS Pharmaceutical Co., Ltd.
公开号:US05922767A1
公开(公告)日:1999-07-13
Disclosed herein are substituted benzylurea derivatives represented by the following general formula (1): ##STR1## wherein R.sup.1 and R.sup.2 are independently H, a halogen atom, or an alkyl or alkoxyl group, R.sup.3 is a phenyl or heterocyclic group which may be substituted, n is an integer of 1-6, and R.sup.4 is a phenyl group which may be substituted, or salts thereof, and medicines comprising such a derivative as an active ingredient. The derivatives or salts thereof strongly inhibit only ACAT in macrophages and are hence useful as prophylactic and therapeutic agents for arteriosclerosis.
本文披露了以下一般式(1)所代表的取代苯甲酰脲衍生物:其中R.sup.1和R.sup.2独立地为H、卤素原子或烷基或烷氧基基团,R.sup.3为苯基或可能被取代的杂环基团,n为1-6的整数,R.sup.4为可能被取代的苯基团,或其盐,以及包含该衍生物作为活性成分的药物。这些衍生物或其盐强烈抑制巨噬细胞中的ACAT,因此可用作动脉粥样硬化的预防和治疗剂。